# Production Sign-off and Release Governance

## Verified status

The project has passed the current release-quality gate based on fresh validation in the workspace.

- Backend validation: 30 tests passed, 0 failed
- Dataset readiness: `production_ready = true`
- Operational dataset size: 20,080 rows
- Medicines covered: 20
- Unique days covered: 1,004
- Date range: 2024-01-01 to 2026-09-30
- Forecast quality: MAE 0.6574, RMSE 1.1551

## Conclusion

The system is ready for the next operational phase as a production-style pilot with human review controls in place. The current forecast is evidence for decision support, not autonomous inventory action.

## Release rules

1. Keep the current operational dataset as the approved baseline for future comparisons.
2. Treat forecasting as advisory and human-reviewed.
3. Require a reviewer decision before any operational action is taken from forecast output.
4. Record every recommendation, review action, and override in the audit trail.
5. Continue monitoring data drift and model quality before broader rollout.

## Required next actions

- Freeze the approved operational dataset and model baseline.
- Review the forecast risk and replenishment recommendation workflow.
- Verify audit logging for every recommendation decision.
- Confirm that no stock movement is triggered without a signed review.
- Use the project checklists in this repository for deployment and release sign-off.

## Commands for final verification

```bash
cd "c:\Users\aakas\Documents\PlayGround 2.0\PharmaSense"
python research/check_data_readiness.py
cd backend
npm test
```

## Related project documents

- [README.md](../README.md)
- [RELEASE_CHECKLIST.md](./RELEASE_CHECKLIST.md)
- [DEPLOYMENT_RUNBOOK.md](./DEPLOYMENT_RUNBOOK.md)
- [SECURITY_REVIEW.md](./SECURITY_REVIEW.md)
- [DATABASE_QUALITY.md](./DATABASE_QUALITY.md)

## Sign-off statement

This project is now in the controlled pilot-release phase and should proceed with governance, auditability, and human review as the release gate.
